Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.
Saved in:
| Title: | Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study. |
|---|---|
| Authors: | Mamakou V; Medical School, National and Kapodistrian University Athens, 75 M. Assias Street, 115 27, Athens, Greece. vmamakou@hotmail.com.; Dromokaiteio Psychiatric Hospital, 124 61, Athens, Greece. vmamakou@hotmail.com., Hackinger S; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK., Zengini E; Dromokaiteio Psychiatric Hospital, 124 61, Athens, Greece.; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Tsompanaki E; School of Information Sciences and Technology, Department of Statistics, Athens University of Economics and Business, 10434, Athens, Greece., Marouli E; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, EC1M 6BQ, London, UK., Serafetinidis I; Department of Gastroenterology, Gennimatas General Hospital, 11527, Athens, Greece., Prins B; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK., Karabela A; Dafni Psychiatric Hospital, 12462, Athens, Greece., Glezou E; Dromokaiteio Psychiatric Hospital, 124 61, Athens, Greece., Southam L; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Rayner NW; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.; Oxford Centre for Diabetes Endocrinology and Metabolism, Oxford, UK., Kuchenbaecker K; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK., Lamnissou K; National and Kapodistrian University of Athens, Department of Biology, Athens, Panepistimioupolis, AnoIlisia, 15771, Athens, Greece., Kontaxakis V; Early Psychosis Unit, 1st Department of Psychiatry, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece., Dedoussis G; Department of Nutrition-Dietetics, Harokopio University, 17671, Athens, Greece., Gonidakis F; 1st Psychiatric Department, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece., Thanopoulou A; Diabetes Centre, 2nd Department of Internal Medicine, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece., Tentolouris N; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Medical School, Laiko General Hospital, 11527, Athens, Greece., Zeggini E; Wellcome Sanger Institute, Hinxton, Cambridge, HH, CB10 1, UK. |
| Source: | BMC psychiatry [BMC Psychiatry] 2018 Aug 02; Vol. 18 (1), pp. 249. Date of Electronic Publication: 2018 Aug 02. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-244X |
|---|---|
| DOI: | 10.1186/s12888-018-1826-4 |
